Aims
====

To evaluate the effects of dopexamine on haemodynamics and renal function in patients undergoing surgical renal artery reconstruction (RARS).

Methods
=======

Ten patients (aged 54 to 75; 7 males), scheduled for RARS were randomised, following cardiovascular optimisation, to receive either dopexamine (1 μg/kg/min), introduced 2 h before surgery and continued for 24 h after surgery (DPX, *n* = 5), or placebo (PLA, *n* = 5). Anaesthesia was similar in both groups. Pre-operatively, all patients were assessed by renal angiography. Renal function was assessed by plasma creatinine, creatinine clearance and iohexol clearance \[[@B1]\]. Haemodynamics and splanchnic perfusion were assessed by invasive cardiovascular monitoring and gastric tonometry respectively. Data are expressed as mean ± SD. Statistics: Student\'s *t* test was used.

Results
=======

The 2 groups were comparable with reference to demographic data and surgical procedures (POSSUM predicted risks:DPX mortality 21%, morbidity 72%; PLA mortality 22%, morbidity 75%). There was 1 death in each group in the first 8 weeks after surgery. Data was incomplete for iohexol clearance due to technical difficulties (numbers in subscript).There was no significant difference between the groups in iohexol or creatinine clearance (Iox, CreaCl, ml/min), plasma creatinine (Great, μmol/l), urinary volumes (UrVol, l), pHi, oxygen delivery (DO~2~I) and consumption (VO~2~I, ml/min/m^2^) and oxygen extraction ratio (%). Results are shown in the table overleaf (\**P* \< 0.1, significance = *P* \< 0.05):

Conclusion
==========

In this small group, dopexamine at this dose did not appear to offer a significant benefit to patients undergoing RARS.

              Pre Drug      Post Ind\'n    DPX End Surg.   24 h post      2--4 months      re Drug        post Ind\'n   PLA End Surg.   4 h post       2--4 month
  ----------- ------------- -------------- --------------- -------------- ---------------- -------------- ------------- --------------- -------------- -------------
  lox         74.3± 31.23                                  62 ± 51.84                      86 ± 29.94                                   53.6 ± 21.25   
  CreaCl                                                   56.7 ± 38.3                                                                  51.3 ± 21.6    
  Creat       138 ± 63.5                                   184.2 ± 92.7   109.3 ± 23^\*^   109.4 ± 25.7                                 174 ± 50.7     132.7 ± 9.8
  \% ΔCreat                                                30.3 ± 31.4                                                                  66.6 ± 61.5    
  UrVol(24)                                                2.1 ± 1.03                                                                   3.2 ± 1.05     
  pHi                       7.39 ± 0.05    7.35 ± 0.09     7.28 ± 0.14                                    7.39 ± 0.1    7.37 ± 0.04     7.29 ± 0.06    
  DO21        458 ± 87      520 ± 93^\*^   699 ± 163^\*^   643 ± 224                       512 ± 78       412 ± 57      516 ± 81        552 ± 70       
  VO21        112 ± 11      85 ± 40        101 ± 40        162 ± 71                        130 ± 23       87 ± 7        83 ± 21         151 ± 26       
  O2ER        24 ± 3        16 ± 6         14 ± 5          26 ± 7                          26 ± 7         21 ± 3        16 ± 6          27 ± 5         
